Mark S. Schroeder - 11 Feb 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, Pres Diagnostics & COO
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
11 Feb 2024
Net transactions value
-$28,659
Form type
4
Filing time
13 Feb 2024, 12:11:29 UTC
Previous filing
08 Feb 2024
Next filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +472 +6.2% 8,091 11 Feb 2024 Direct F1
transaction LH Common Stock Tax liability $28,659 -126 -1.6% $227.45 7,965 12 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -472 -2.9% $0.000000 15,621 11 Feb 2024 Common Stock 472 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.
F4 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.